Mehrpouri, Mahdieh <br/><br/>
Anti-leukemic effects of histone deacetylase (HDAC) inhibition in acute lymphoblastic leukemia (ALL) cells: Shedding light on mitigating effects of NF-κB and autophagy on panobinostat cytotoxicity.  [electronic resource] 

 -  European journal of pharmacology  May 2020 
 - 173050 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1879-0712 
<br/><br/><label>Standard No.: </label>10.1016/j.ejphar.2020.173050  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Apoptosis--drug effects<br/>Autophagy--drug effects<br/>Bortezomib--pharmacology<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Drug Synergism<br/>Epigenesis, Genetic--drug effects<br/>G1 Phase--drug effects<br/>Gene Expression Regulation, Leukemic--drug effects<br/>Histone Deacetylase Inhibitors--pharmacology<br/>Humans<br/>NF-kappa B--antagonists & inhibitors<br/>Panobinostat--pharmacology<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Signal Transduction--drug effects<br/>Vincristine--pharmacology